6.
Desalegn H, Aberra H, Berhe N, Gundersen S, Johannessen A
. Are non-invasive fibrosis markers for chronic hepatitis B reliable in sub-Saharan Africa?. Liver Int. 2017; 37(10):1461-1467.
PMC: 5637891.
DOI: 10.1111/liv.13393.
View
7.
Afdhal N, Bacon B, Patel K, Lawitz E, Gordon S, Nelson D
. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol Hepatol. 2014; 13(4):772-9.e1-3.
DOI: 10.1016/j.cgh.2014.12.014.
View
8.
Stabinski L, Reynolds S, Ocama P, Laeyendecker O, Ndyanabo A, Kiggundu V
. High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antivir Ther. 2011; 16(3):405-11.
PMC: 3142695.
DOI: 10.3851/IMP1783.
View
9.
Myers R, Pomier-Layrargues G, Kirsch R, Pollett A, Beaton M, Levstik M
. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol. 2011; 56(3):564-70.
DOI: 10.1016/j.jhep.2011.10.007.
View
10.
Sulkowski M, Mehta S, Torbenson M, Afdhal N, Mirel L, Moore R
. Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus. AIDS. 2005; 19(6):585-92.
DOI: 10.1097/01.aids.0000163935.99401.25.
View
11.
Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M
. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005; 128(2):343-50.
DOI: 10.1053/j.gastro.2004.11.018.
View
12.
Myers R, Crotty P, Pomier-Layrargues G, Ma M, Urbanski S, Elkashab M
. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int. 2010; 30(10):1471-80.
DOI: 10.1111/j.1478-3231.2010.02331.x.
View
13.
Fallatah H, Akbar H, Fallatah A
. Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease. Hepat Mon. 2016; 16(7):e38346.
PMC: 5018361.
DOI: 10.5812/hepatmon.38346.
View
14.
Hartl J, Denzer U, Ehlken H, Zenouzi R, Peiseler M, Sebode M
. Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis. J Hepatol. 2016; 65(4):769-775.
DOI: 10.1016/j.jhep.2016.05.023.
View
15.
Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F
. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005; 41(1):48-54.
DOI: 10.1002/hep.20506.
View
16.
Behairy B, Sira M, Zalata K, Salama E, Abd-Allah M
. Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?. World J Gastroenterol. 2016; 22(16):4238-49.
PMC: 4837441.
DOI: 10.3748/wjg.v22.i16.4238.
View
17.
Toosi A
. Liver Fibrosis: Causes and Methods of Assessment, A Review. Rom J Intern Med. 2016; 53(4):304-14.
DOI: 10.1515/rjim-2015-0039.
View
18.
Floreani A, Cazzagon N, Martines D, Cavalletto L, Baldo V, Chemello L
. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis. 2011; 43(11):887-92.
DOI: 10.1016/j.dld.2011.06.011.
View
19.
Auerbach B, Reynolds S, Lamorde M, Merry C, Kukunda-Byobona C, Ocama P
. Traditional herbal medicine use associated with liver fibrosis in rural Rakai, Uganda. PLoS One. 2012; 7(11):e41737.
PMC: 3507824.
DOI: 10.1371/journal.pone.0041737.
View
20.
Mehta S, Lau B, Afdhal N, Thomas D
. Exceeding the limits of liver histology markers. J Hepatol. 2008; 50(1):36-41.
PMC: 2637134.
DOI: 10.1016/j.jhep.2008.07.039.
View